IDXX Idexx Laboratories Inc

Price (delayed)

$489.21

Market cap

$41.73B

P/E Ratio

83.91

Dividend/share

N/A

EPS

$5.83

Enterprise value

$42.53B

Sector: Healthcare
Industry: Diagnostics & Research

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and ...

Highlights

The company's equity has surged by 118% YoY and by 61% QoQ
The quick ratio has soared by 64% YoY and by 23% QoQ
IDXX's price to earnings (P/E) is 58% higher than its 5-year quarterly average of 53.1 and 47% higher than its last 4 quarters average of 57.2

Key stats

What are the main financial stats of IDXX
Market
Shares outstanding
85.3M
Market cap
$41.73B
Enterprise value
$42.53B
Valuations
Price to earnings (P/E)
83.91
Price to book (P/B)
94.44
Price to sales (P/S)
16.11
EV/EBIT
67.99
EV/EBITDA
59.1
EV/Sales
16.41
Earnings
Revenue
$2.59B
EBIT
$625.51M
EBITDA
$719.54M
Free cash flow
$446.12M
Per share
EPS
$5.83
Free cash flow per share
$5.23
Book value per share
$5.18
Revenue per share
$30.37
TBVPS
$20.58
Balance sheet
Total assets
$2.05B
Total liabilities
$1.61B
Debt
$973.95M
Equity
$440.58M
Working capital
$341.84M
Liquidity
Debt to equity
2.21
Current ratio
1.65
Quick ratio
0.97
Net debt/EBITDA
1.11
Margins
EBITDA margin
27.8%
Gross margin
57.6%
Net margin
19.2%
Operating margin
24.1%
Efficiency
Return on assets
25.8%
Return on equity
199.3%
Return on invested capital
31.9%
Return on capital employed
41.1%
Return on sales
24.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IDXX stock price

How has the Idexx Laboratories stock price performed over time
Intraday
-0.74%
1 week
-0.05%
1 month
-1.6%
1 year
74.24%
YTD
-2.13%
QTD
-2.13%

Financial performance

How have Idexx Laboratories's revenue and profit performed over time
Revenue
$2.59B
Gross profit
$1.49B
Operating income
$625.06M
Net income
$497.48M
Gross margin
57.6%
Net margin
19.2%
The company's net income rose by 18% YoY and by 8% QoQ
IDXX's operating income is up by 13% YoY and by 5% from the previous quarter
The gross profit has increased by 12% YoY and by 5% QoQ
IDXX's revenue is up by 10% year-on-year and by 4.7% since the previous quarter

Growth

What is Idexx Laboratories's growth rate over time

Valuation

What is Idexx Laboratories stock price valuation
P/E
83.91
P/B
94.44
P/S
16.11
EV/EBIT
67.99
EV/EBITDA
59.1
EV/Sales
16.41
IDXX's price to earnings (P/E) is 58% higher than its 5-year quarterly average of 53.1 and 47% higher than its last 4 quarters average of 57.2
The company's EPS rose by 19% YoY and by 8% QoQ
The company's equity has surged by 118% YoY and by 61% QoQ
The price to book (P/B) is 24% less than the last 4 quarters average of 124.2
The P/S is 96% above the 5-year quarterly average of 8.2 and 53% above the last 4 quarters average of 10.5
IDXX's revenue is up by 10% year-on-year and by 4.7% since the previous quarter

Efficiency

How efficient is Idexx Laboratories business performance
Idexx Laboratories's return on equity has shrunk by 51% YoY and by 18% QoQ
Idexx Laboratories's return on invested capital has decreased by 4.2% YoY
The return on assets rose by 4% since the previous quarter
The company's return on sales rose by 2.6% YoY

Dividends

What is IDXX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IDXX.

Financial health

How did Idexx Laboratories financials performed over time
The company's total assets is 27% higher than its total liabilities
The quick ratio has soared by 64% YoY and by 23% QoQ
IDXX's current ratio is up by 47% year-on-year and by 15% since the previous quarter
The debt is 121% more than the equity
The company's equity has surged by 118% YoY and by 61% QoQ
IDXX's debt to equity has shrunk by 55% YoY and by 45% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.